Correlation Between Merck and HANSOH PHARMAC
Can any of the company-specific risk be diversified away by investing in both Merck and HANSOH PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and HANSOH PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and HANSOH PHARMAC HD 00001, you can compare the effects of market volatilities on Merck and HANSOH PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of HANSOH PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and HANSOH PHARMAC.
Diversification Opportunities for Merck and HANSOH PHARMAC
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Merck and HANSOH is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and HANSOH PHARMAC HD 00001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HANSOH PHARMAC HD and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with HANSOH PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HANSOH PHARMAC HD has no effect on the direction of Merck i.e., Merck and HANSOH PHARMAC go up and down completely randomly.
Pair Corralation between Merck and HANSOH PHARMAC
Assuming the 90 days horizon Merck Company is expected to generate 0.28 times more return on investment than HANSOH PHARMAC. However, Merck Company is 3.63 times less risky than HANSOH PHARMAC. It trades about 0.17 of its potential returns per unit of risk. HANSOH PHARMAC HD 00001 is currently generating about -0.17 per unit of risk. If you would invest 14,045 in Merck Company on October 10, 2024 and sell it today you would earn a total of 455.00 from holding Merck Company or generate 3.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Merck Company vs. HANSOH PHARMAC HD 00001
Performance |
Timeline |
Merck Company |
HANSOH PHARMAC HD |
Merck and HANSOH PHARMAC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and HANSOH PHARMAC
The main advantage of trading using opposite Merck and HANSOH PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, HANSOH PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HANSOH PHARMAC will offset losses from the drop in HANSOH PHARMAC's long position.Merck vs. ALBIS LEASING AG | Merck vs. FUYO GENERAL LEASE | Merck vs. United Natural Foods | Merck vs. CN MODERN DAIRY |
HANSOH PHARMAC vs. PLAY2CHILL SA ZY | HANSOH PHARMAC vs. Aristocrat Leisure Limited | HANSOH PHARMAC vs. MEDCAW INVESTMENTS LS 01 | HANSOH PHARMAC vs. Scottish Mortgage Investment |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |